Shanghai Aladdin Biochemical Technology Co. Ltd. A
Shanghai Aladdin Biochemical Technology Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of scientific research reagents in China and internationally. It offers chemistry and biochemicals reagents, including blocks, ligands, catalysts, chemical synthesis, laboratory chemicals, chemical biology, analytical standards, CVD and ALD precursors, and s… Read more
Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179) - Total Liabilities
Latest total liabilities as of June 2025: CN¥681.91 Million CNY
Based on the latest financial reports, Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179) has total liabilities worth CN¥681.91 Million CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Shanghai Aladdin Biochemical Technology Co. Ltd. A - Total Liabilities Trend (2019–2024)
This chart illustrates how Shanghai Aladdin Biochemical Technology Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Shanghai Aladdin Biochemical Technology Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Shanghai Aladdin Biochemical Technology Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cecep Environmental Protection Equipment Co Ltd
SHE:300140
|
China | CN¥16.01 Billion |
|
BASF India Limited
NSE:BASF
|
India | ₹38.85 Billion |
|
Jiangxi Sanxin Medtec Co Ltd
SHE:300453
|
China | CN¥833.14 Million |
|
Zhejiang Zanyu Technology Co Ltd
SHE:002637
|
China | CN¥4.60 Billion |
|
Build-A-Bear Workshop Inc
NYSE:BBW
|
USA | $175.88 Million |
|
Companhia de Saneamento do Paraná - SANEPAR
SA:SAPR3
|
Brazil | R$13.97 Billion |
|
Pharmicell
KO:005690
|
Korea | ₩19.60 Billion |
|
China Zhonghua Geotechnical Engineering Co Ltd
SHE:002542
|
China | CN¥4.85 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Shanghai Aladdin Biochemical Technology Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.65 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.66 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai Aladdin Biochemical Technology Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai Aladdin Biochemical Technology Co. Ltd. A (2019–2024)
The table below shows the annual total liabilities of Shanghai Aladdin Biochemical Technology Co. Ltd. A from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥635.25 Million | +35.40% |
| 2023-12-31 | CN¥469.15 Million | -6.92% |
| 2022-12-31 | CN¥504.03 Million | +583.09% |
| 2021-12-31 | CN¥73.79 Million | +57.50% |
| 2020-12-31 | CN¥46.85 Million | +5.49% |
| 2019-12-31 | CN¥44.41 Million | -- |